Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: a need for more translational study

J Hepatol. 2012 Apr;56(4):753-5. doi: 10.1016/j.jhep.2011.12.006. Epub 2012 Jan 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis B e Antigens / blood*
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / immunology*
  • Humans
  • Interleukins / blood*
  • Male
  • Nucleosides / therapeutic use*
  • Pyrimidinones / therapeutic use*
  • Telbivudine
  • Thymidine / analogs & derivatives

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Interleukins
  • Nucleosides
  • Pyrimidinones
  • Telbivudine
  • interleukin-21
  • Thymidine